FDA Approves AbbVie’s Juvmo for Parkinson Disease
FDA Approves AbbVie's Juvmo for Parkinson Disease Drug Topics
Regulatory Approvals
Roundup: FDA Approves Lilly’s Olumiant, AbbVie’s Juvmo, Mirum & Incyte’s Atebrioz
Roundup: FDA Approves Lilly’s Olumiant, AbbVie’s Juvmo, Mirum & Incyte’s Atebrioz Pharmaceutical Executive
FDA Approves First Treatment for MCT8 Deficiency
The U.S. Food and Drug Administration today approved Emcitate (tiratricol) tablets for oral suspension to treat peripheral thyrotoxicosis (excess thyroid…
Lupin wins tentative US FDA approval for apixaban oral suspension
Lupin wins tentative US FDA approval for apixaban oral suspension Dealroom.co
FDA approves Mirum’s oral drug for rare disease FOP
FDA approves Mirum's oral drug for rare disease FOP pharmaphorum.com